Union Budget 2026 Lays Foundation for Biopharma Growth and Affordable Care
New Delhi | February 1, 2026 The Union Budget 2026–27 has placed healthcare firmly at the centre of India’s growth […]
New Delhi | February 1, 2026 The Union Budget 2026–27 has placed healthcare firmly at the centre of India’s growth […]
India’s active pharmaceutical ingredient (API) manufacturers have urged the government to introduce import curbs and support for GMP upgrades in […]
As the Union Budget 2026 approaches, the pharmaceutical industry is seeking policy measures focused on customs duty rationalisation, increased R&D […]